Patient-perceived anxiety levels associated with use of selective serotonin and serotonin norepinephrine reuptake inhibitors.
Dental practitioners are sometimes reluctant to treat patients who are on psychopharmacological agents, due perhaps to the belief that these patients will be difficult to deal with. However patients whose medical history indicates emotional and psychiatric disorders and who are being treated with SSRI or SSNRI agents may actually present a more positive and more receptive attitude to treatment than what was sometimes previously encountered in these same individuals.
Weiner
Arthur A
AA
Tufts University School of Dental Medicine, USA.
Stark
Paul S
PS
Gunawardena
Dilshan
D
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D016854:Dental Anxiety / Q000523:psychology*; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D010342:Patient Acceptance of Health Care / Q000523:psychology; D012647:Self-Assessment; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D018759:Adrenergic Uptake Inhibitors; D009638:Norepinephrine; D017367:Selective Serotonin Reuptake Inhibitors